Literature DB >> 28668701

Cardiopulmonary resuscitation by trained responders versus lay persons and outcomes of out-of-hospital cardiac arrest: A community observational study.

Yoo Mi Park1, Sang Do Shin2, Yu Jin Lee3, Kyoung Jun Song4, Young Sun Ro5, Ki Ok Ahn6.   

Abstract

OBJECTIVES: The study aims to compare bystander processes of care (cardiopulmonary resuscitation (CPR) and defibrillation) and outcomes for witnessed presumed cardiac etiology in OHCA patients in whom initial resuscitation was provided by dedicated trained responder (TR) versus lay person (LP) bystanders.
METHODS: Data on witnessed and presumed cardiac OHCA in adults (15 years or older) from 2011 to 2015 in a metropolitan city with 10 million persons were collected, excluding cases in which the information on TRs, bystander CPR, defibrillation, and clinical outcomes was unknown. Exposure variables were TRs who were legally designated with CPR education and response and LPs who were bystanders who witnessed the OHCA by chance. The primary/secondary/tertiary outcomes were a good cerebral performance category (CPC) of 1 or 2, survival to discharge, and bystander defibrillation. A multivariable logistic regression analysis was used to calculate the adjusted odds ratio (AOR) with 95% confidence intervals (CIs), adjusting for potential confounders.
RESULTS: Of 20,984 OHCA events, 6475 cases were ultimately analyzed. The TR group constituted 6.4% of the cases, and the patients showed significantly better survival and a good CPC. From the multivariable logistic regression analysis of the outcomes, by comparing the TR group with the LP group, the AOR (95% CIs) was 1.49 (1.04-2.15) for a good CPC, 1.59 (1.20-2.11) for survival to discharge, and 10.02 (7.04-14.26) for bystander defibrillation.
CONCLUSION: The TR group witnessed a relatively low proportion of OHCA but was associated with better survival outcomes and good neurological recovery through higher CPR rates and defibrillation of adults older than 15 years with witnessed OHCA in a metropolitan city.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac arrest; Cardiopulmonary resuscitation; Defibrillation; Trained responder

Mesh:

Year:  2017        PMID: 28668701     DOI: 10.1016/j.resuscitation.2017.06.024

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  5 in total

1.  Out of hospital cardiac arrest: experience of a bystander CPR training program in Karachi, Pakistan.

Authors:  Uzma Rahim Khan; Umerdad Khudadad; Noor Baig; Fareed Ahmed; Ahmed Raheem; Butool Hisam; Nadeem Ullah Khan; Marcus Ong Eng Hock; Junaid Abdul Razzak
Journal:  BMC Emerg Med       Date:  2022-06-03

2.  Effect of topography and weather on delivery of automatic electrical defibrillator by drone for out-of-hospital cardiac arrest.

Authors:  Dong Sun Choi; Ki Jeong Hong; Sang Do Shin; Chang-Gun Lee; Tae Han Kim; Youngeun Cho; Kyoung Jun Song; Young Sun Ro; Jeong Ho Park; Ki Hong Kim
Journal:  Sci Rep       Date:  2021-12-17       Impact factor: 4.379

Review 3.  [Ethics of resuscitation and end of life decisions].

Authors:  Spyros D Mentzelopoulos; Keith Couper; Patrick Van de Voorde; Patrick Druwé; Marieke Blom; Gavin D Perkins; Ileana Lulic; Jana Djakow; Violetta Raffay; Gisela Lilja; Leo Bossaert
Journal:  Notf Rett Med       Date:  2021-06-02       Impact factor: 0.826

4.  Effect of a first responder on survival outcomes after out-of-hospital cardiac arrest occurs during a period of exercise in a public place.

Authors:  Seo Young Ko; Young Sun Ro; Sang Do Shin; Kyoung Jun Song; Ki Jeong Hong; So Yeon Kong
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

5.  Place-provider-matrix of bystander cardiopulmonary resuscitation and outcomes of out-of-hospital cardiac arrest: A nationwide observational cross-sectional analysis.

Authors:  Dae Kon Kim; Sang Do Shin; Young Sun Ro; Kyoung Jun Song; Ki Jeong Hong; So Yeon Joyce Kong
Journal:  PLoS One       Date:  2020-05-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.